首页> 外文期刊>日本臨牀 >Recent progress on the searchs of pathogenesis of thyrotoxic periodic paralysis
【24h】

Recent progress on the searchs of pathogenesis of thyrotoxic periodic paralysis

机译:甲状腺毒性周期性麻痹的发病机理研究新进展

获取原文
获取原文并翻译 | 示例
           

摘要

In Japan, more than 60% of hypokalemic periodic paralysis is thyrotoxic instead of familial type frequently experienced in Caucasian countries. The pathogenesis of familial hypokalemic periodic paralysis (FHPP) has been elucidated to be due to the mutation of one of the genes in either Ca(CACN1AS), Na(SCN4A) or K channel(KCNE3). Clinical features of thyrotoxic periodic paralysis (TPP) is very similar to that of FHPP and rigorous attempts have been devoted to the search of the gene mutation of ion channels in TPP. To date, however, no such an attempt has been successful except for the findings of SNiPs in those ion channel genes or in the vicinity of TRE of CACN1AS. Those SNiPs may provide a risk to the attack of TPP. In TPP, we and others reported that the serum insulin level tremendously elevated prior to the attack of paralysis. There were clinical evidences indicating that hypokalemic periodic paralysis is caused by the depolarization block of muscle cell membrane instead of hyperpolarization block once assumed previously. Otsuka reported that insulin can induce depolarization block of muscle membrane in low K concentration by increasing membrane permeability to Na. We have reported that K deficiency and thyroid hormone excess increased NaK-ATPase and may sensitize the muscle membrane to the effect of insulin to cause depolarization in an animal model. In fact, in Japan, incidence of TPP of male decreased from 8.6% in 1958 to 4.3% in 1998. During this 40 years, intake of K was increased from 43 to 65 mEq per day per person as described by the National Survey of Nutrition. The SNiPs of ion channel genes, together with K deficiency or thyroid hormone excess, may provide a risk to the occurrence of TPP.
机译:在日本,超过60%的低钾型周期性麻痹是甲状腺毒性的,而不是白种人国家经常发生的家族性麻痹。家族性低钾性周期性麻痹(FHPP)的发病机理已阐明是由于Ca(CACN1AS),Na(SCN4A)或K通道(KCNE3)中的一种基因突变引起的。甲状腺毒性周期性麻痹(TPP)的临床特征与FHPP非常相似,并且已经进行了严格的尝试来寻找TPP中离子通道的基因突变。然而,迄今为止,除了在那些离子通道基因中或在CACN1AS的TRE附近发现SNiP以外,没有任何这样的尝试成功。这些SNiP可能会威胁到TPP的攻击。在TPP中,我们和其他人报道了麻痹发作之前血清胰岛素水平大大升高。有临床证据表明,低钾性周期性麻痹是由肌肉细胞膜的去极化阻滞而不是先前假设的超极化阻滞引起的。大冢报道,在低钾浓度下,胰岛素可以通过增加膜对钠的渗透性来诱导肌膜去极化阻滞。我们已经报道,在动物模型中,钾缺乏和甲状腺激素过量会增加NaK-ATPase,并可能使肌膜对胰岛素的作用引起去极化。实际上,在日本,男性TPP的发病率从1958年的8.6%下降到1998年的4.3%。在这40年中,根据国家营养调查,钾的摄入量从每人每天43 mEq增加到了每天65 mEq。 。离子通道基因的SNiPs以及钾缺乏症或甲状腺激素过多可能会给TPP的发生带来风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号